Calcified chondroid mesenchymal neoplasm is a term proposed for tumors with a spectrum of morphologic features, including cartilage/chondroid matrix formation, that frequently harbor FN1 gene fusions. We report a series of 33 cases of putative calcified chondroid mesenchymal neoplasms, mostly referred for expert consultation out of concern for malignancy. Patients included 17 males and 16 females, with a mean age of 51.3 years. Anatomic locations include the hands and fingers, feet and toes, head and neck, and temporomandibular joint; 1 patient presented with multifocal disease. Radiologic review showed soft tissue masses with variable internal calcification, which occasionally scalloped bone but in all cases appeared indolent/benign. Tumors had a mean gross size of 2.1 cm and a homogenous rubbery to fibrous/gritty tan-white cut surface. Histology demonstrated multinodular architecture with a prominent chondroid matrix and increased cellularity towards the periphery of the nodules. The tumor cells were polygonal with eccentric nuclei and bland cytologic features and showed a variable amount of increased spindled / fibroblastic forms in the perinodular septa. The majority of cases had notable grungy and/or lacy calcifications. A subset of cases demonstrated at least focal areas of increased cellularity and osteoclast-like giant cells. Herein, we confirm the distinct morphologic and clinicopathologic features associated with this entity with the largest series to date, with a focus on practical diagnostic separation from similar chondroid neoplasms. Awareness of these features is critical in avoiding pitfalls, including a malignant diagnosis of chondrosarcoma.

Biopticka Laboratory Pilsen Czech Republic

Department of Pathology and Laboratory Medicine University of Kansas School of Medicine Kansas City KS

Department of Pathology Immunology and Laboratory Medicine Rutgers New Jersey Medical School Rutgers NJ

Department of Pathology Johns Hopkins Medicine Baltimore MD

Department of Pathology Stanford Medicine Stanford CA

Department of Pathology University of Maryland School of Medicine

Institut Bergonié Centre Hospitalier Universitaire de Bordeaux Bordeaux France

Physicians Laboratory

University of South Dakota Sanford School of Medicine Sioux Falls SD

Zobrazit více v PubMed

Liu YJ, Wang W, Yeh J, et al. Calcified chondroid mesenchymal neoplasms with FN1-receptor tyrosine kinase gene fusions including FGFR2, FGFR1, MERTK, NTRK1, and TEK: a molecular and clinicopathologic analysis. Mod Pathol. 2021;34:1373–1383.

Puls F, Hofvander J, Magnusson L, et al. FN1-EGF gene fusions are recurrent in calcifying aponeurotic fibroma. J Pathol. 2016;238:502–507.

Amary F, Perez-Casanova L, Ye H, et al. Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement. Mod Pathol. 2019;32:1762–1771.

Lee JC, Jeng YM, Su SY, et al. Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour. J Pathol. 2015;235:539–545.

Bouvier C, Nihous H, Macagno N. [Soft tissue tumours with FN1 (Fibronectin 1) fusion gene]. Ann Pathol. 2022;42:242–248.

Kao YC, Lee JC, Huang HY. What is new about the molecular genetics in matrix-producing soft tissue tumors?-The contributions to pathogenetic understanding and diagnostic classification. Virchows Arch. 2020;476:121–134.

Cates JM, Rosenberg AE, O’Connell JX, et al. Chondroblastoma-like chondroma of soft tissue: an underrecognized variant and its differential diagnosis. Am J Surg Pathol. 2001;25:661–666.

Folpe AL, Fanburg-Smith JC, Billings SD, et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol. 2004;28:1–30.

Hoch BL, Garcia RA, Smalberger GJ. Chondroid tenosynovial giant cell tumor: a clinicopathological and immunohistochemical analysis of 5 new cases. Int J Surg Pathol. 2011;19:180–187.

Oda Y, Izumi T, Harimaya K, et al. Pigmented villonodular synovitis with chondroid metaplasia, resembling chondroblastoma of the bone: a report of three cases. Mod Pathol. 2007;20:545–551.

Ishida T, Dorfman HD, Bullough PG. Tophaceous pseudogout (tumoral calcium pyrophosphate dihydrate crystal deposition disease). Hum Pathol. 1995;26:587–593.

Tretiakova MS, Wang W, Wu Y, et al. Gene fusion analysis in renal cell carcinoma by FusionPlex RNA-sequencing and correlations of molecular findings with clinicopathological features. Genes Chromosomes Cancer. 2020;59:40–49.

Mantilla JG, Ricciotti RW, Chen E, et al. Detecting disease-defining gene fusions in unclassified round cell sarcomas using anchored multiplex PCR/targeted RNA next-generation sequencing-Molecular and clinicopathological characterization of 16 cases. Genes Chromosomes Cancer. 2019;58:713–722.

Raparia K, Lin JW, Donovan D, et al. Chondroblastoma-like chondroma of soft tissue: report of the first case in the base of skull. Ann Diagn Pathol. 2013;17:298–301.

Agaimy A, Michal M, Chiosea S, et al. Phosphaturic mesenchymal tumors: clinicopathologic, immunohistochemical and molecular analysis of 22 cases expanding their morphologic and immunophenotypic spectrum. Am J Surg Pathol. 2017;41:1371–1380.

Board WCoTE. WHO Classification of Tumours of Soft Tissue and Bone. 5 ed. Lyon: IARC; 2020.

Agaram NP, Zhang L, Dickson BC, et al. A molecular study of synovial chondromatosis. Genes Chromosomes Cancer. 2020;59:144–151.

Zhao Z, Paquette C, Shah AA, et al. Fine needle aspiration cytology of diffuse-type tenosynovial giant cell tumors. Acta Cytol. 2017;61:160–164.

Nagase M, Araki A, Ishikawa N, et al. Tenosynovial giant cell tumor, localized type with extensive chondroid metaplasia: a case report with immunohistochemical and molecular genetic analysis. Int J Surg Pathol. 2020;28:447–453.

Kurihara K, Mizuseki K, Saiki T, et al. Tophaceous pseudogout of the temporomandibular joint: report of a case. Pathol Int. 1997;47:578–580.

Houghton D, Munir N, Triantafyllou A, et al. Tophaceous pseudogout of the temporomandibular joint with erosion into the middle cranial fossa. Int J Oral Maxillofac Surg. 2020;49:1286–1289.

Bouvier C, Le Loarer F, Macagno N, et al. Recurrent novel THBS1-ADGRF5 gene fusion in a new tumor subtype “Acral FibroChondroMyxoid Tumors”. Mod Pathol. 2020;33:1360–1368.

Ossifying fibromyxoid tumours with lipomatous and cartilaginous differentiation: A diagnostic pitfall